Literature DB >> 16096643

14-3-3eta is a novel regulator of parkin ubiquitin ligase.

Shigeto Sato1, Tomoki Chiba, Eri Sakata, Koichi Kato, Yoshikuni Mizuno, Nobutaka Hattori, Keiji Tanaka.   

Abstract

Mutation of the parkin gene, which encodes an E3 ubiquitin-protein ligase, is the major cause of autosomal recessive juvenile parkinsonism (ARJP). Although various substrates for parkin have been identified, the mechanisms that regulate the ubiquitin ligase activity of parkin are poorly understood. Here we report that 14-3-3eta, a chaperone-like protein present abundantly in neurons, could bind to parkin and negatively regulate its ubiquitin ligase activity. Furthermore, 14-3-3eta could bind to the linker region of parkin but not parkin with ARJP-causing R42P, K161N, and T240R mutations. Intriguingly, alpha-synuclein (alpha-SN), another familial Parkinson's disease (PD) gene product, abrogated the 14-3-3eta-induced suppression of parkin activity. alpha-SN could bind tightly to 14-3-3eta and consequently sequester it from the parkin-14-3-3eta complex. PD-causing A30P and A53T mutants of alpha-SN could not bind 14-3-3eta, and failed to activate parkin. Our findings indicate that 14-3-3eta is a regulator that functionally links parkin and alpha-SN. The alpha-SN-positive and 14-3-3eta-negative control of parkin activity sheds new light on the pathophysiological roles of parkin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16096643      PMCID: PMC1356342          DOI: 10.1038/sj.emboj.7600774

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  46 in total

Review 1.  Specificity of 14-3-3 isoform dimer interactions and phosphorylation.

Authors:  A Aitken; H Baxter; T Dubois; S Clokie; S Mackie; K Mitchell; A Peden; E Zemlickova
Journal:  Biochem Soc Trans       Date:  2002-08       Impact factor: 5.407

Review 2.  14-3-3 proteins in the nervous system.

Authors:  Daniela Berg; Carsten Holzmann; Olaf Riess
Journal:  Nat Rev Neurosci       Date:  2003-09       Impact factor: 34.870

3.  alpha-Synuclein locus triplication causes Parkinson's disease.

Authors:  A B Singleton; M Farrer; J Johnson; A Singleton; S Hague; J Kachergus; M Hulihan; T Peuralinna; A Dutra; R Nussbaum; S Lincoln; A Crawley; M Hanson; D Maraganore; C Adler; M R Cookson; M Muenter; M Baptista; D Miller; J Blancato; J Hardy; K Gwinn-Hardy
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

4.  Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.

Authors:  K K Chung; Y Zhang; K L Lim; Y Tanaka; H Huang; J Gao; C A Ross; V L Dawson; T M Dawson
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

5.  alpha-Synuclein is phosphorylated in synucleinopathy lesions.

Authors:  Hideo Fujiwara; Masato Hasegawa; Naoshi Dohmae; Akiko Kawashima; Eliezer Masliah; Matthew S Goldberg; Jie Shen; Koji Takio; Takeshi Iwatsubo
Journal:  Nat Cell Biol       Date:  2002-02       Impact factor: 28.824

6.  Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.

Authors:  Jin Xu; Shyan-Yuan Kao; Frank J S Lee; Weihong Song; Lee-Way Jin; Bruce A Yankner
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

7.  Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine.

Authors:  Eunsung Junn; M Maral Mouradian
Journal:  Neurosci Lett       Date:  2002-03-08       Impact factor: 3.046

8.  14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains.

Authors:  Yasuhiro Kawamoto; Ichiro Akiguchi; Shinichi Nakamura; Yasuyuki Honjyo; Hiroshi Shibasaki; Herbert Budka
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

Review 9.  Molecular pathways of neurodegeneration in Parkinson's disease.

Authors:  Ted M Dawson; Valina L Dawson
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

10.  An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.

Authors:  Todd B Sherer; Ranjita Betarbet; Amy K Stout; Serena Lund; Melisa Baptista; Alexander V Panov; Mark R Cookson; J Timothy Greenamyre
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

View more
  44 in total

Review 1.  Regulation of Parkin E3 ubiquitin ligase activity.

Authors:  Helen Walden; R Julio Martinez-Torres
Journal:  Cell Mol Life Sci       Date:  2012-04-19       Impact factor: 9.261

2.  14-3-3 proteins in neurological disorders.

Authors:  Molly Foote; Yi Zhou
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

3.  14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.

Authors:  H Ding; R Underwood; N Lavalley; T A Yacoubian
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

4.  DEGAS: de novo discovery of dysregulated pathways in human diseases.

Authors:  Igor Ulitsky; Akshay Krishnamurthy; Richard M Karp; Ron Shamir
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

5.  14-3-3zeta contributes to tyrosine hydroxylase activity in MN9D cells: localization of dopamine regulatory proteins to mitochondria.

Authors:  Jian Wang; Haiyan Lou; Courtney J Pedersen; Amanda D Smith; Ruth G Perez
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

Review 6.  Progress in the pathogenesis and genetics of Parkinson's disease.

Authors:  Yoshikuni Mizuno; Nobutaka Hattori; Shin-Ichiro Kubo; Shigeto Sato; Kenya Nishioka; Taku Hatano; Hiroyuki Tomiyama; Manabu Funayama; Yutaka Machida; Hideki Mochizuki
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

7.  Differential interaction of the E3 ligase parkin with the proteasomal subunit S5a and the endocytic protein Eps15.

Authors:  Susan S Safadi; Gary S Shaw
Journal:  J Biol Chem       Date:  2009-10-29       Impact factor: 5.157

8.  Fbxo45, a novel ubiquitin ligase, regulates synaptic activity.

Authors:  Hirobumi Tada; Hirotaka James Okano; Hiroshi Takagi; Shinsuke Shibata; Ikuko Yao; Masaki Matsumoto; Toru Saiga; Keiichi I Nakayama; Haruo Kashima; Takuya Takahashi; Mitsutoshi Setou; Hideyuki Okano
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

9.  Identification of chaperones in a MPP+-induced and ATRA/TPA-differentiated SH-SY5Y cell PD model.

Authors:  Hongrong Xie; Hui Hu; Ming Chang; Dongya Huang; Xiaobo Gu; Xinli Xiong; Ran Xiong; Linsen Hu; Gang Li
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

10.  14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization.

Authors:  R Jeremy Nichols; Nicolas Dzamko; Nicholas A Morrice; David G Campbell; Maria Deak; Alban Ordureau; Thomas Macartney; Youren Tong; Jie Shen; Alan R Prescott; Dario R Alessi
Journal:  Biochem J       Date:  2010-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.